New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Eikon Therapeutics, Inc. (EIKN) vs SAB Biotherapeutics, Inc. (SABS)
- Eikon Therapeutics, Inc. EIKN 4.74 −0.42%
- SAB Biotherapeutics, Inc. SABS 2.81 −3.44%
Eikon Therapeutics, Inc. and SAB Biotherapeutics, Inc. are both Biotechnology companies. Eikon Therapeutics, Inc. and SAB Biotherapeutics, Inc. are of similar size ($262.2M and $257.9M). Across the 10 metrics below, Eikon Therapeutics, Inc. leads on 5 and SAB Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | EIKN | SABS | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | — | (1,647.03%) | 0.00% |
| Net margin | — | (1,450.32%) | 0.00% |
| Free cash flow margin | — | (1,344.29%) | 0.00% |
| Return on equity | 359.35% | (47.62%) | (51.58%) |
| Return on assets | (56.31%) | (42.73%) | (45.91%) |
| Return on invested capital | 0.00% | (48.38%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack